Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03110653Completed
Randomised, double-blind trial of remifentanil in postoperative pain (2 arms), sponsored by Université libre de Bruxelles. Primary endpoint: First demand of postoperative analgesic. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03110653.